Anemia is a common complication of chronic kidney disease (CKD) and is associated with a
decrease in quality of life and an increased risk of transfusions, morbidity and mortality, and …

This work presents an update on the management of iron deficiency in patients with chronic
kidney disease (CKD), either with or without anaemia. A review is made of the …

The development of clinical practice guidelines for the treatment of anemia in chronic kidney
disease has been instrumental in identifying and reducing variations in the use of …

This clinical practice guideline provides recommendations on the management of anaemia
of chronic kidney disease (CKD) and serves as an update of the 4th edition module …

The Optimal Renal Anaemia Management Assessment trial prospectively examined the
impact of implementing European Best Practice Guidelines on outcomes in the management …

Anemia is a common complication of chronic kidney disease (CKD) and is associated with
poor outcomes. Erythropoietin (EPO) deficiency is the primary cause, but absolute or relative …

Background It is of paramount importance not only to publish anaemia management
guidelines for chronic kidney disease (CKD) but also to verify their implementation in clinical …

Abstract Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) group has
produced comprehensive clinical practice guidelines for the management of anaemia in …

Sažetak Erythropoiesis-stimulating agents (ESAs) administered either subcutaneously (sc.)
or intravenously (iv.), along with iv. or oral iron therapy, are currently the cornerstones for …

Anemia is a well-known consequence of chronic kidney disease (CKD); it is mainly due to a
relative insufficiency of erythropoietin synthesis by the failing kidneys. Over the years, the …